Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | RORC | P51449 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21135709 | 0.87 | KMT2A (0.36) | L3MBTL1KMT2AMEN1TDP1RORC | |
| SCHEMBL21135693 | 0.83 | ALDH1A1 (0.36) | KMT2ATDP1RORCCYP2D6MAPK1 | |
| SCHEMBL21135755 | 0.81 | KMT2A (0.33) | L3MBTL1KMT2AMEN1TDP1RORC | |
| SCHEMBL21136598 | 0.77 | MEN1 (0.34) | L3MBTL1KMT2AMEN1TDP1RORC | |
| SCHEMBL21135699 | 0.75 | SMN1; SMN2 (0.38) | KMT2AMEN1HPGD | |
| SCHEMBL15858326 | 0.75 | ALDH1A1 (0.34) | KMT2AMEN1HPGDGAANPC1 | |
| SCHEMBL12452801 | 0.73 | ALDH1A1 (0.43) | L3MBTL1KMT2AMEN1HPGDGAA | |
| SCHEMBL14037156 | 0.72 | KMT2A (0.44) | L3MBTL1KMT2AMEN1TDP1NPC1 | |
| SCHEMBL21135780 | 0.71 | ALDH1A1 (0.34) | L3MBTL1 | |
| SCHEMBL21136388 | 0.71 | NAAA (0.37) | L3MBTL1KMT2AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190196326-A1 | ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM, PATTERN FORMING METHOD, AND METHOD OF MANUFACTURING ELECTRONIC DEVICE | FUJIFILM CORPORATION (JP) | 2019-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190196326-A1 | ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM, PATTERN FORMING METHOD, AND METHOD OF MANUFACTURING ELECTRONIC DEVICE | RER1, ACTR5, RAD51 | L3MBTL1 4400/4885KMT2A 3332/4885MEN1 2511/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.